TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
INKT

Mink Therapeutics Inc

Healthcare · Biotechnology

12.10$ -0.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement INKT
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% – – 100.0% – – –
– – – 0.0% – – –
100.0% – – 0.0% – – –
2,850.0% – – 0.9% – – –
555.1% – – 0.3% – – –
3,331.4% – – 1.1% – – –
-3,231.4% – – -1.1% – – –
226.3% – – 0.0% – – –
-3,451.5% – – -1.0% – – –
306.3% – – -0.1% – – –
-3,451.5% – – -1.0% – – –
-3,219.8% – – -1.0% – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?